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 Abstract 
Avian influenza poses a threat to many species including man, as shown by the 
current scenario in Southeast Asia. It appears that this particular type of influenza 
virus can spread to many species causing severe disease in these new species. For 
example, from 258 human cases 154 were fatal (WHO, 2006-11-29). Why some 
avian influenza virus have the ability to infect other species remains to be 
understood. One viral gene, coding for the non-structural protein 1 (NS1), appears 
to be an important factor for successfully transmission into a new host, by counter-
acting the new host’s immune system. The exact mechanism of action of NS1 is 
still unclear, but leads to down-regulation of various pathways of the immune 
defence. The aim of this study was to express NS1 proteins of influenza viruses 
originating from different hosts, including highly pathogenic avian influenza 
viruses, for use in investigations on the mechanism used by NS1 to interfere with 
the immune system of various hosts. In particular, studies on the interaction of 
NS1 with the RNA dependent protein kinase (PKR) were initiated, to determine 
differences in this interaction between high and low pathogenic influenza viruses 
from different hosts. By establishing tools and optimised assays, the work enables 
further studies on the role NS1 in immune evasion. 
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BACKGROUND 
History of influenza 
Influenza is a contagious respiratory viral illness of global importance, caused by 
influenza virus. Influenza viruses have unique features among respiratory viruses, 
with the segmented genome and considerable antigenic diversity. They have been 
classified into three distinct types: A, B and C. Influenza A is responsible for 
occasional pandemics affecting millions of people worldwide, often associated 
with considerable morbidity and mortality. During the years 1918-1920, it caused 
one of the most destructive disease outbreaks in world history that become known 
as the Spanish flu pandemic. It resulted in the death of an estimated 50-100 million 
people (Johnson and Muller, 2002); thus, this influenza pandemic killed more 
people than the World War I. It is not known where the pandemic started but it has 
been suggested that it originated during the First World War, in the northern part 
of France (Oxford et al., 2005). Most parts of the world were affected. In Sweden 
about 35.000 people died from this disease. For unknown reasons the disease 
disappeared after this devastating outbreak. The disease occurred in the United 
States in 1924-25, and then again in 1929 in a much milder form. This virus 
continued to circulate in humans until 1957. It was then replaced by another 
human influenza virus, the Asian flu virus. Pandemic influenza A viruses emerged 
three times during the last century: in 1918 (H1N1 subtype), in 1957 (H2N2), and 
in 1968 (H3N2) (Cox and Subbarao, 2000; Webby and Webster 2003). Currently 
both H3N2 and H1N1, a late fifties variant that re-appeared in 1977, co-circulate 
in humans. 
  
The recent circulation of highly pathogenic avian H5N1 viruses in Asia from 
2003–to date has caused at least 258 human cases 154 were fatal as of November 
29th 2006 (Peiris et al., 2004, World Health Organization, WHO) and has raised 
concern about the development of a new pandemic like the Spanish Flu (Cox and 
Subbarao, 2000). How and when novel influenza viruses emerge as pandemic 
strains and their mechanism of pathogenesis is still not understood. 
 
At the time of the great Spanish flu it was not known that the disease was caused 
by a virus. However, the causative agent of influenza in birds, the so-called fowl 
plague, was shown to be a ‘virus’ as early as 1901. It was not until 1955 that its 
relationship with other milder viruses isolated from birds, and with mammalian 
influenza A viruses (first isolated in the 1930s) was demonstrated (Schafer, 1955). 
In 1933 Smith, Andrewes and Laidlaw isolated the virus in ferrets (Smith, 
Andrewes and Laidlaw, 1933). 
 
Meanwhile, Tumpey et al. (2005) reporting in Science show that the reconstructed 
1918 Spanish influenza virus kills mice faster than any other influenza virus so far 
tested. So, there appears to be some viral factor that is especially potent. 
 
 Influenza A is classified into subtypes based on antigenic and genetic differences 
of the two viral surface proteins, HA and NA. To date, 16 HA and 9 NA subtypes 
have been detected in wild birds and poultry throughout the world (World Health 
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Organization 1980, Fouchier et al., 2005). All 16 HA and 9 NA subtypes in the 
majority of possible combinations have been isolated from wild avian species 
(Alexander, 2000). The most recent type (H16) was isolated from black-headed 
gulls caught in Sweden in 1999 (Fouchier et al., 2005). 
Influenza A viruses infecting poultry can be divided into two groups. The very 
virulent viruses cause ‘fowl plague’, now termed highly pathogenic avian 
influenza (HPAI), in which mortality may be as high as 100%. There are also 
avian influenza viruses causing milder symptoms and these are referred to as low 
pathogenic avian influenza (LPAI). HPAI viruses are always of the H5 or H7 
subtypes, however, there are LPAI viruses within the H5 and H7 subtypes as well. 
In wild birds throughout the world influenza viruses representing 16 HA and 9 NA 
antigenic subtypes have been detected in numerous combinations (Fouchier et al., 
2005). Low pathogenic influenza A virus strains may, after circulation in chickens 
or other domestic birds mutate into highly pathogenic influenza strains (Alexander 
et al., 2000). 
 
 Influenza A viruses have been isolated from many species, including humans, 
pigs, horses, mink, marine mammals and wide range of domestic and wild birds 
(Murphy and Webster 1996, Webster et al., 1992). Horses and swine are affected 
by influenza viruses, showing symptoms rather similar to humans. The virus 
comprise the subtypes H3N8 in equine and H1N1, H3N2 and H1N2 in swine. 
Equine influenza outbreaks are common also in Sweden but swine influenza 
appears only to cause milder symptoms in swine and is not commonly noted. The 
first isolation of high pathogenic influenza virus from feral birds was in 1961 from 
common terns (Sterna hirundo) in South Africa (Becker, 1996), but it was not until 
the mid-1970s that any systematic investigation of influenza in feral birds was 
undertaken. These revealed the enormous pools of influenza viruses now known to 
be present in the wild bird populations. Wild birds such as wild waterfowl, 
shorebirds and gulls are the main reservoirs of influenza viruses.  All influenza 
virus strains infecting mammalian species originate from wild birds (Webster et 
al., 1992). 
 
Genome Structure and function 
 
As mentioned earlier influenza is caused by influenza A virus. Influenza A viruses 
are negative sense, single-stranded RNA viruses, which together with influenza B, 
C and Thogotovirus, belong to the family Orthomyxoviridae. Influenza B can also 
cause similar symptoms as Influenza A, but generally in a milder form. Influenza 
C viruses infect mammals only, and generally do not cause disease. They are 
genetically distinct from A and B types. Of all influenza viruses, the leading cause 
of significant disease in both humans and animals is infection with influenza A.  
The following text only describes influenza type A virus. A model of the virus is 
shown in Figure1. 
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Figure 1. A model of influenza virus, showing the two types of surface proteins, 
haemagglutinin and neuraminidase, and the segmented genome. Source: www.psc.edu 
 
 
The viral genome consists of eight segments of single stranded RNA of so-called negative 
polarity. Each of these segments encodes one polypeptide, except for PB1 segment, 
which encodes a protein called PB1-F2, and the two smallest ones that encode two 
proteins each. A total of 11 known proteins are encoded by the genome. The three 
largest segments (1, 2 and 3) encode polymerase proteins, PB1, PB2 and PA that 
are responsible for RNA synthesis. Segment numbers 4 and 6 encode surface 
proteins, hemagglutinin (HA) and neuraminidase (NA) that are involved in 
attachment, fusion between the viral envelope and cellular membrane, and release 
of virus particles. The 5th segment encodes a Nucleoprotein (NP) that protects the 
viral RNA, but has also other functions. The 7th segment encodes the M1 and M2 
proteins. M1 is a matrix protein that covers the inner surface of the viral 
membrane. M2 forms an ion-channel that is important in the early steps of 
infection by lowering the pH and allows conformation changes if the HA, that then 
mediates the fusion process. The last segment encodes two proteins: non-structural 
protein 1 (NS1) and nuclear export protein (NEP), which are involved in various 
aspects in the process of taking over the host cell. The NS1 protein is not present 
in the virion but only expressed in infected cells. 
 
Influenza A is one of infrequent viruses that have its genome in separate segments. 
This increases the potential for recombinants, so-called gene reassortants to form, 
and may contribute to the rapid development of new influenza strains in nature. 
 
 
 The virus life cycle 
 
The life cycle of influenza virus is summarised in Figure 2. Attachment of 
influenza A virus requires sialic acid as receptor. However, strains vary in their 
affinities for different sialyloligosaccharides. For example, avian and equine virus 
strains prefer sialic acids attached to galactose with α-2,3 linkages (Connor et al., 
1994, Rogers and Paulson 1983), while human virus strains prefer the α-2,6 
linkages. Hemagglutinin is the viral glycoprotein that binds to the cell receptor, 
sialic acid. The HA monomer is synthesized as a precursor that is glycosylated and 
cleaved into HA1 and HA2 subunits in order to successfully infect cells 
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(Steinhauer, 1999). Receptor-bound viruses are taken into the cell by endocytosis. 
In the low pH environment of the endosome, viral envelope fuses with the lipid 
bilayer of the vesicle, releasing the viral ribonucleoprotein (RNP) into the cell 
cytoplasm, from where it is transported into the nucleus. New viral proteins are 
translated from transcribed messenger RNA (mRNA), and the viral RNA is 
replicated from the negative stranded templates. The new viral RNA, is then 
encapsidated by the NP protein, and after acquiring the new matrix protein, is 
transported to sites at the cell surface where envelope HA and NA components are 
incorporated from the cell membrane. Progeny virions are formed and then 
released from the cell by budding.   
 
. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The infection cycle of influenza virus. Adapted from Stannard, 1995.  
 
Influenza virus reservoir (wild birds) 
 
Wild birds such as wild waterfowl, shorebirds and gulls are the main reservoirs of 
avian influenza viruses. Migratory waterfowl - most notably wild ducks - are the 
natural reservoir of avian influenza viruses, and these birds are also the most 
resistant to infection. They can carry the virus over great distances. In their natural 
host the viruses appear, in most cases, to be non–pathogenic. From this reservoir, 
virus can be transmitted to domestic birds or other hosts. All known influenza 
strains infecting humans and mammals originally circulated in the wild bird 
population (Ito and Kawaoka, 2000; Reid et al., 1999). As everyone is aware of, 
the aggressive form of the “avian flu” has been detected also in Sweden, with a 
number of cases in wild birds such as tufted ducks, swans, owl and also a wild 
mink. To date about 65 cases have been proven positive for the highly pathogenic 
H5N1 virus. 
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Aquatic birds are the reservoir of avian influenza virus. In Sweden the swans and 
tufted ducks were the most affected by HPAI infection. (Photo: Bengt Ekberg and 
Erik Ågren) 
 
Influenza in domestic birds 
 
Domestic birds such as chickens, turkeys and ducks are highly susceptible to 
avian influenza virus.  Direct or indirect contact of domestic flocks with wild 
migratory waterfowl has been implicated as a frequent cause of epidemics 
(Webster et al., 1992). Millions of birds died from the disease or had to be culled 
in order to stop the outbreaks (Capua, 2001). The outbreaks in domestic birds 
have increased during the last years (Munster et al., 2005). Live bird markets 
have also played an important role in the spread of epidemics. Also, water, where 
infected animals feed and live can have enormous quantities of viruses and act as 
source of infections. 
 
Influenza A virus transmission to mammalian species 
 
Influenza is not only a human disease as mentioned earlier. It is known to cause 
several of the most devastating diseases in other mammals as well. Influenza A 
viruses have been isolated from a variety of mammals, including pigs, horses, sea 
mammals, and mink (Webster et al., 1992). Examples of bird to mammal 
transmission of influenza viruses have been reported (Callan et al., 1995; Geraci et 
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al., 1982; Guo et al., 1992; Hinshaw et al., 1986; Hinshaw et al., 1984; Klingeborn 
et al., 1985; Lvov et al., 1978, Scholtissek et al., 1983). 
 
In 1979, an H1N1 avian virus was transmitted to pigs and is still circulating in this 
species (Pensaert et al., 1981, Scholtissek et al., 1983). In Southern China in 1996, 
an H1N1 virus was transmitted from birds to pigs (Guan et al., 1996) but it does 
not appear to be circulating in these hosts at present. Avian virus strains have been 
found in pigs for example, a H4N6 strain in Canada (Karasin et al., 2000).  Viruses 
other than the H1, H3, N1, N2 and N7 subtypes have not been isolated from pigs. 
  
Transmission of influenza virus to humans occurs occasionally and has often been 
fatal (Rota et al., 1989).  Beginning in 1979, in Europe, human H3N2 and avian 
H1N1 viruses co-circulated in pigs, and eventually re-assorted in this host 
(Castrucci et al., 1993) generating a virus with its HA and NA genes from the 
human H3N2 virus and the remainder from the avian virus.  In 1992, this 
reassortant virus was isolated from ill children in the Netherlands (Claas et al., 
1994). This incident support the theory that pigs serve as mixing vessels for the 
generation of avian-human reassortants, with the potential to cause human 
pandemics (Scholtissek et al., 1988). In England, an avian influenza with an 
unusual subtype (H1N7) was isolated (Brown et al., 1994). Two of its genes (NA 
and M) appear to be of equine origin, while the others seem to have originated in 
humans. Pigs are liable to variety of influenza viruses and should be monitored 
regularly. 
 
Transmission of an avian virus to horses was reported in a notable case of severe 
outbreak of respiratory disease in 1989, causing about 20% mortality (Guo et al., 
1992). This new virus was named A/-Equine/Jilin/1/89 (H3N8), but later analyses 
demonstrated its avian origin. This virus disappeared for unknown reasons. Mink 
has been found to be naturally infected by avian Influenza A virus of the subtype 
H10N4 in Blekinge, Sweden (Klingeborn et al., 1985). This was one of the first 
examples of a direct transmission of avian influenza into a mammalian species 
(Klingeborn et al., 1985). Interestingly, during the outbreak of H5N1 in wild bird 
in early spring 2006 in Sweden, this virus has also been isolated from mink. There 
are also examples when influenza viruses were introduced from avian species to 
other mammals such as seals (Geraci et al., 1982, Lang at al., 1981) whales 
(Hinshaw et al., 1984) tigers and leopards (Keawcharoen et al., 2004) and in cats 
(Yinqst et al., 2006). 
 
 
Influenza A virus transmission to humans 
 
There are only three known A subtypes of human influenza viruses (H1N1, H2N2, 
and H3N2). As mentioned earlier, both H3N2 and H1N1 are currently circulating 
among humans. It is proven that some genes of circulating human influenza A 
viruses came from birds originally. In fact, the current H3N2 carries 5 genes from 
the “Spanish flu” influenza virus, while the PB1, HA and NA have been replaced 
via avian influenza viruses. Influenza A (H5N1) virus – also called H5N1 virus is 
a subtype that occurs mainly in birds. H5N1 virus does not usually infect people, 
but infections with these viruses have occurred mostly resulting from direct or 
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close contact with H5N1 infected poultry or contaminated premises. Recent 
examples show a transmission of H5N1 virus directly from chicken to humans 
already in 1997, where 6 out of 18 infected people died (De Jong et al., 1997; 
Class et al., 1998; Subbarao et al., 1998) and an H7N7 transmission associated 
with one fatal case (Foucier et al., 2004). The current data as of 2006-11-29 shows 
a total of 258 confirmed cases with 154 deaths (www. who.int/en). The cases are 
from Azerbaijan (8/5), Cambodia (6/6), China (21/14), Djibouti (1/0), Egypt 
(15/7), Indonesia (74/56), Iraq (3/2), Thailand (25/17), Turkey (12/4), Viet Nam 
(93/42). The death rates are unusually high, about 50 per cent. It is not known 
whether milder forms of this disease occur.  
 
 
Pathogenicity of avian influenza in other species 
 
The common pathogenic feature for all HPAI has been the presence of a stretch of 
basic amino acids in the HA protein, rendering it to be easily cleaved by 
ubiquitous proteases. The cleaving of HA into two subunits is a requirement for 
virus infectivity. The situation in mammals cannot be explained by this cleavage 
ability. There are several examples, like the previously mentioned cases in mink 
some years ago, where the HA of this virus was not of the “easy cleavage kind” 
(Feldmann et al., 1988). Another example is the HA of the Spanish flu that do not 
have this typical hallmark. Obviously, other factors are important in the 
introduction of influenza into new species and further spread in that species. The 
current H5N1 outbreak is, however, caused by a typical HPAI HA (Viseshakul et 
al., 2004; Suarez et al., 1998). Thus, the HA may contribute to pathogenicity but is 
not the sole explanation.  
 
In addition to the “infectivity issue” one major determinant for pathogenicity is the 
virus’ ability to cope with the immune system of the new host. The H5N1 
influenza virus that was transmitted to humans in 1997 is an example of this. The 
virus was highly virulent in humans, and unlike other human and avian viruses, 
was shown to be resistant to the innate immune system as exemplified by 
interferon (IFN) and tumor necrosis factor α (TNFα) (Seo et al., 2002). This 
resistance was attributed to the NS1 protein of the virus. There are more 
substantial data pointing to a central role of the NS1 in pathogenesis of influenza 
virus infection (Basler et al., 2001; Zejun et al., 2006). The NS1 of avian influenza 
has evolved to be resistant to the avian IFN system and TNF-α defense, and 
opposite. The exact functions of NS1 are unclear at the moment. Several 
publications have shown that NS1 has many activities, including down regulation 
of IFN expression (Geiss et al., 2002), binding to and preventing mRNA 
processing (Noah et al., 2003), RNA silencing suppressor (Otilia Delgado et al., 
2004; Bucher et al., 2004; Li et al., 2004). In all cases, the effects of NS1 lead to 
crippled host innate defense. A daunting scenario is that an avian influenza may 
acquire an extremely potent human, or animal NS1 protein and, thereby, gain the 
ability to bypass the innate immune defense and cause worldwide pandemics in 
humans or animals. 
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Aims of this study 
 
The hypothesis behind this study is that there are differences in the ability of NS1 
proteins from influenza viruses isolated from different species to circumvent the 
host immune response. This could be a major factor in enabling the virus to change 
host specificity and cross the host species barrier. Thus, the overall aim of this 
study was to increase the understanding on NS1 and its role in the potential of 
avian influenza viruses to jump the host species barrier. In particular, the aim was: 
i) to express NS1 proteins from avian influenza viruses originating from different 
species, for further biochemical and biological studies; ii) to initiate studies on 
protein-protein interactions and on shut-down of IFN production. 
 
 
Results and discussion 
 
Expression of NS1 proteins from AIV originating from different species 
A number of NS1 expression constructs were produced, comprising clones of high 
pathogenic (mink, Eurasian eagle-owl (eagle-owl), low pathogenic avian viruses, 
and other non-typed viruses of human origin. As shown in Figure 1, in the 
manuscript all the clones express the NS1 protein, evaluated by correct expected 
size (26 KDa). NS1 proteins from different AIV subtypes were expressed to high 
levels in the TNT system. The NS1 from mink and eagle-owl, the HPAI used in 
this study, were slightly shorter than the ones expressed from the remaining clones 
(LPAIV). This corresponds to a short, five amino acid deletions in the middle of 
the protein (Zohari et al., personal communication). 
The hypothesis behind this study is that there are differences in the ability of NS1 
proteins from avian influenza viruses isolated from different hosts to circumvent 
the host immune response. This could be a major factor in enabling influenza virus 
to change host specificity. In particular, we were interested to determine if 
influenza NS1 proteins originating from different hosts may differ in their ability 
to interact with the interferon induced and double-stranded RNA activated protein 
kinase (PKR). This protein has to be an essential component of the IFN-mediated 
cellular antiviral response (Li et al., 2006). This antiviral effect is achieved 
through blocking of the viral protein synthesis by phosphorylation of the 
translation initiation factor eIF-2 (Samuel et al., 1993) NS1 has previously been 
shown to inhibit this activity.To study this, NS1 proteins from AIV deriving from 
different host species were expressed in the TNT system for use as prey in GST 
pull-down assays. PKR proteins from different hosts were also expressed as fusion 
to GST and used as bait in the assays. The preliminary results of the GST pull-
down assays could not be evaluated due to background signals, and the assay is 
under optimization to enable completion of the studies. Nevertheless, this work has 
produced tools for use in further studies on the functions of NS1. For example, by using the 
NS1 clones it was possible to obtain data that indicates that NS1 of LPAI viruses are better 
at inhibiting interferon production than HPAI virus (Örlen, H, poster presentation to 
USGBR). This unexpected result is interesting and is currently under more detailed 
investigation. It has been shown that NS1 of avian influenza A virus binds PKR and blocks 
its activation during virus infection (Shoudong et al., 2006). The completion of the 
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experiments from the present studies will be important to determine whether the established 
interaction is species specific, and if it differs between high and low pathogenic avian 
influenza viruses. 
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Abstract 
 
Avian influenza is a potential threat to many species including man. The viral gene 
encoding the NS1 protein is presumed to be an important factor for evasion of the 
innate immune system and, therefore, important for a successful transmission of 
the virus to a new host. The exact mechanism behind this function of NS1 is still 
unclear. Previous studies have shown that NS1 has different effects in the immune 
system, among them down-regulation of interferon (IFN) expression, inhibition of 
activation of the RNA dependent protein kinase (PKR). The aim of this study was 
to investigate whether these effects are species specific. NS1 proteins from avian 
influenza viruses originating from different hosts, as well as PKR proteins of 
horse, human and chicken origin were expressed. These were used to initiate 
studies on NS1-PKR interactions and on shutdown of IFN production. The 
completion of the experiments from these studies will be important to determine whether 
the interaction is species specific, and if it differs between high and low pathogenic avian 
influenza viruses. 
 
 
Introduction  
Influenza is caused by Influenza A virus, which together with Influenza B and C 
and Thogotovirus, belongs to the family Ortomyxoviridae. Of all influenza viruses, 
the leading cause of significant disease in both humans and animals is Influenza A 
infection. Influenza A viruses have the potential to cause devastating pandemics 
(Palese, 2004) and may cross species barriers as a whole and adapt to a new host 
(Ludwig et al., 1995; Webster et al., 1981).  
 
The viral genome consists of eight segments of single-stranded RNA of negative 
polarity. Each of these segments encodes one polypeptide, except for PB1 
segment, which encodes a protein called PB1-F2, and the two smallest ones that 
encode two proteins each. A total of 11 known proteins are encoded by the 
genome. The three largest segments (1, 2 and 3) encode polymerase proteins, PB1, 
PB2 and PA that are responsible for RNA synthesis. Segment number 4 and 6 
encode surface proteins, hemagglutinin (HA) and neuraminidase (NA) that are 
involved in attachment, fusion between the viral envelope and cellular membrane, 
and release of virus particles. The 5th segment encodes a Nucleoprotein (NP) that 
protects the viral RNA, but has also other functions. The 7th segment encodes the 
M1 and M2 proteins. M1 is a matrix protein that covers the inner surface of the 
viral membrane. M2 forms an ion-channel that is important in the early steps of 
infection by lowering the pH and allows conformation changes if the HA that then 
mediates the fusion process. The last segment encodes two proteins; non-structural 
protein 1 (NS1) and nuclear export protein (NEP), which are involved in various 
aspects in the process of taking over the host cell. The NS1 protein is not present 
in the virion but only expressed in infected cells. 
 
Influenza A is classified in subtypes, based on antigenic and genetic differences in 
the two viral surface proteins, HA and NA. Sixteen different HA subtypes (H1-
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H16) and nine NA (N1-N9) subtypes have been identified. From avian species all 
16 HA and 9 NA subtypes have been isolated in the majority of possible 
combinations (Alexander, 2000). The most recent subtype (H16) was isolated from 
black-headed gulls caught in Sweden and the Netherlands in 1999 (Fouchier, 
2005). 
  
Influenza A viruses have been isolated from many species, including humans, 
pigs, horses, mink, marine mammals and wide range of domestic and wild birds 
(Fouchier et al., 2005; Webster et al., 1992). Wild birds, predominantly ducks, 
geese and shorebirds form the reservoir of influenza A viruses in nature. The 
viruses do not cause disease in the reservoir, however when in contact with 
susceptible hosts, infection is transmitted and may result in devastating disease. 
 
To be able to successfully transmit into the new host avian influenza has to cope 
with the immune system of the new host. Several studies have shown that a viral 
gene, coding for the NS1 protein is involved in different roles including down-
regulation of IFN expression (Geiss et al., 2002), binding to and preventing 
mRNA processing (Noah et al, 2003), RNA silencing suppressor (Otilia-Delgado 
et al., 2004; Bucher et al., 2004). All the described effects of NS1 lead to crippled 
host innate defence, suggesting an important role of NS1 in immune evasion. 
Therefore, understanding the functions of the NS1 protein is needed in order to 
elucidate the mechanism of immune evasion and to determine the factors behind 
jumping of host species barrier.  
 
 
Materials and Methods  
 
Viruses 
Avian influenza viruses, representing both HPAI and LPAI subtypes and 
originating from different host species (wild birds, mink, eagle-owl, chicken and 
human) were used in this study. The viruses were obtained from NVI, either as 
alantoic fluid preparations, that were used as source of RNA, or as extracted RNA 
(HPAI and other non-typed viruses of human origin). The samples included: 
H7N7, H4N6, H12N5, H6N8, H5N1, among others. 
 
RNA-extraction 
RNA was extracted with TRIzol LS Reagent (Invitrogen,USA), according to the 
manufacturer’s instructions. Briefly, 250μl of samples were mixed with 750 μl of 
TRIzol and incubated for 5 minutes at room temperature. Afterwards, 200μl of 
chloroform was added, and the tubes were shaken vigorously for 15 sec and then 
centrifuged at 13 000 rpm (Sigma, Germany) for 15 minutes. The RNA was 
collected from the supernatant and precipitated overnight with 500μl of 
isopropanol at -20°C. The precipitated RNA was centrifuged at 13 000 rpm for 20 
minutes at 4°C and then washed with cold 75% ethanol. The resulting pellets were 
air dried, re-suspended in 30μl of DMPC water and stored at -20°C for further use. 
 
Synthesis of cDNA 
A mix of 5μl RNA, 2μl of pdN6 (1:10) and 3μl of DMPC water was denatured at 
65°C for 10 minutes and then chilled on ice. The reverse transcription mix 
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comprised 5μl of 5×first standard buffer (Invitrogen), 2μl of DTT, 2.5μl of mM 
dNTP mix (Amersham Biosciences) 24U of RNA guard (Amersham Biosciences) 
and 200U of Moloney murine leukaemia virus reverse transcriptase. Transcription 
was performed at 37°C for 90 min followed by the inactivation of enzyme at 95°C 
for 5 min. 
 
PCR for amplification of the NS1 gene of AIV  
The reaction mixture of 50μl, comprised 30μl of sterile distilled water; 5 μl of 
10×PCR buffer; 1μl of 10mM dNTP mix; 2μl of each 10μM primer; 3μl of 25 mM 
MgCl; 1U of Taq DNA (Ampli Taq, Perkin-Elmer); and 5 μl of cDNA. 
Thermocyling profile included initial denaturation at 95°C for 2min, followed by 
35 cycles of denaturation at 94°C for 45sec; annealing at 56°C for 60 sec; and 
extension at 72°C for 90 sec and a final extension at 72°C for 7 min. These were 
amplified on a PTC-200 Peltier Termal Cycler machine. 
  
RT-PCR for amplification of PKR from different cell types (chicken, human, horse) 
Extraction of RNA was done using the Trizol reagent, as described before, from 
lysates of a B cell line, HEK 293T, and equine dermal cells, as source of chicken, 
human and equine PKR, respectively.  Synthesis of cDNA was also performed as 
described before, except that a reverse primer specific for each PKR type was 
used. The reaction mixture for the PCR contained 33.5μl of sterile distilled water, 
5 μl of 10×PCR buffer, 1μl of 10mM dNTP mix, 2μl of each 10μM primer, 4μl of 
25 mM MgCl; 2U of Taq DNA polymerase (Ampli Taq, Perkin-Elmer); and 2.5 μl 
of cDNA. The thermocyling profile included initial denaturation at 95°C for 2min, 
95°C for 30sec; annealing at 59°C for 30 sec; 72°C for 1.30min-30 cycles, 72°C 
for 7 min final extension and 4°C hold. 
 
All the primers used in the RT-PCRs are listed in Table 1 
 
Table 1. Primers used in RT-PCR amplifications 
 
Name Sequence (5’-3’) Purpose 
NS1-AllFORECO CCGAATTCAGCAAAAGCAGGGTGACAAAG NS1PCR forward 
NS1ALLBACKXBA CCTCTAGAAATAGAAACAAGGGTGTTTAT NS1PCR reverse 
NS1 FKPN ATTCGGTACCAGCAAAAGCAGGGTGACAAAG NS1PCR forward 
NS1RXBA TACCTCTAGAAGTAGAAACAAGGGTGTTTTTTAT NS1PCR reverse 
CHPKF CGTGGATCCATGGACCGAGAGTGCATG Chicken PKR PCR forward 
CHPKR TACCTCGAGTTAGTGACTGTAAGC RT, Chicken PCR, reverse 
HUPKF CGTGGATCCATGTCCCAGAGCAGG Human PKR PCR forward 
HUPKR TACCTCGAGTTACTTTCTTTCTGCTAT PT, human PKR PCR, reverse 
For horse were used 
human’s primers 
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The PCR products (5μl) were run on 1% an agarose gel stained with ethidium 
bromide and visualized under UV light. They were then purified using the SV 
Wizard DNA Purification System (Promega). 
 
Cloning of NS1 DNA in pcDNA 3.1+ and of PKR DNA in pGEX-5T 
The NS1 PCR products and the plasmid pCDNA-3.1+ were cleaved with EcoRI 
and XbaI-restriction enzymes (or KpnI-XbaI for NS1 DNA that had an internal 
EcoRI cleavage site). The PKR PCR products and the plasmid PGEX-5T were 
cleaved with BamHI and XhoI restriction enzymes. All DNA cleavages were 
performed following a standard protocol. The digested DNAs were ligated to the 
corresponding vector, using T4 DNA ligase and overnight incubation at 16°C. The 
ligation reactions were used to transform competent DH5α cells, following a 
standard procedure for chemical transformation. Recombinant clones were 
screened by colony PCR with the same primers used generate the respective PCR 
products. Three positive bacteria colonies selected from each transformation were 
used for purification of plasmid mini-preps, using the SV Wizard Plus SV 
Minipreps DNA Purification System (Promega). The mini-preps were then cleaved 
by restriction enzymes to check for presence and correct orientation of the inserts. 
 
Protein expression 
The confirmed NS1 clones were translated in vitro in the coupled 
transcription/translation system (TNT) from Promega, following the 
manufacturer’s instructions, and the option of labeling translation products with 
35S methionine. The GST-PKR proteins were expressed in E coli BL21 cells. 
Optimization of expression conditions was performed by evaluating protein 
production at different time-points, at different temperatures and with different 
concentration of IPTG as inducer. 
 
GST pull-down analysis 
The assays have been described earlier (Berg et al., 1998). In brief, the TNT 
expressed NS1 and GST-PKR were mixed in a small volume in phosphate buffer. 
The proteins were incubated in room temperature for 30 minutes. Then GST-
sepharose beads were added and incubated in a larger volume for three hours. The 
bound proteins were then retrieved on the beads, washed and analyzed on SDS-
PAGE 
 
Results 
 
Expression of NS1 proteins from AIV originating from different hosts 
A number of NS1 expression constructs were produced, comprising clones of high 
pathogenic (mink, eagle-owl), low pathogenic avian viruses, and other non-typed 
viruses of human origin. As shown in Figure 1, all the clones express the NS1 
protein, evaluated by correct expected size (26 KDa). NS1 proteins from different 
AIV subtypes were expressed to high levels in the TNT system. The NS1 from 
mink and eagle-owl, the HPAI used in this study, were slightly shorter than the 
ones expressed from the remaining clones (LPAIV). This corresponds to a short, 
five amino acid deletions in the middle of the protein (Zohari et al., personal 
communication). 
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26 KDa <26 KDa 
Figure 1. Protein expression from NS1 constructs. NS1 genes of different AIV 
were cloned in pCDNA 3.1+ and translated in vitro using the TNT system.  
M: marker; lanes 1 and 11:NS1 control plasmid; lane 2:TNT reaction 
control, no plasmid; lane 3:pGFP-C3 plasmid; lane 4:pNS1-5, lane 
5:pNS1-4; lane 6:pNS1-3; lane 7:pNS1-1; lane 8:pNS1-mink; lane 
9:pNS1- eagle-owl; lane 10:pNS1-mink. 
 
Expression of GST-PKR fusion proteins 
The PKR genes from chicken, human and horse were cloned as fusions to GST in 
pGEX-5T plasmid. They were expressed in E. coli and subsequently tested for 
expression level, solubility and possibility to be purified on GST-beads. As shown 
in Figure 2, fusion proteins of the expected size were expressed. However, the 
level of expression and solubility was different between the chicken, human and 
horse PKR. While high expression levels were obtained for human PKR, protein 
production was lower from horse constructs, and poor from the chicken, on 
repeated experiments at different expression conditions. Nevertheless, the 
solubility of the human and the horse PKR protein was good and suitable for use in 
GST- pull-down experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Expression of GST- PKR fusion proteins. PKR genes were cloned as fusions to 
GST and expressed in BL 21 cells. The human PKR gel (Panel C) shows a time course 
evaluation of protein production, with and without inducers. 
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GST pull down to determine interaction between NS1 and PKR 
An initial GST-pull-down experiment was done using GST-PKR protein bound to 
beads and then the various TNT expressed NS1 protein were added to the beads. 
The proteins were incubated and their interaction assessed after washing the beads 
thoroughly and analyzing the protein by scanning SDS-PAGE gels for radiolabel 
signal. Plain GST protein was used as a negative control. A signal for NS1 could 
be detected in the gels. However, there was a background signal in the negative 
control, which prompted need to optimize the assay to reduce the non-specific 
binding. Dilution of the prey and bait proteins was used in the optimization.  
 
 
Discussion 
 
The hypothesis behind this study is that there are differences in the ability of NS1 
proteins from avian influenza viruses isolated from different hosts to circumvent 
the host immune response. This could be a major factor in enabling influenza virus 
to change host specificity. In particular, we were interested to determine if 
influenza NS1 proteins originating from different hosts may differ in their ability 
to interact with the interferon induced and double-stranded RNA activated protein 
kinase (PKR). To study this, NS1 proteins from AIV deriving from different host 
species were cloned into an eukaryotic expression vector. This strategy will most 
likely render the proteins in an active form. To verify the expression of the various 
NS1 genes we utilized the TNT expression system. These TNT- produced proteins 
were then used as prey in GST pull-down assays. PKR proteins from different 
hosts were also expressed as fusion to GST and used as bait in the assays. The 
preliminary results of the GST pull-down assays could not be evaluated due to 
background signals, and the assay is under optimization to enable completion of 
the studies. Nevertheless, this work has produced tools for use in further studies on the 
functions of NS1. For example, by using the NS1 clones it was possible to obtain data that 
indicates that NS1 of LPAI viruses are better at inhibiting interferon production than HPAI 
virus (Örlen, H, poster presentation to USGBR). This unexpected, but most interesting 
finding is currently investigated in great detail. It has been shown that NS1 of avian 
influenza A virus binds PKR and blocks its activation during virus infection (Shoudong et 
al., 2006). The completion of the experiments from the present studies will be important to 
determine whether the established interaction is species specific, and if it differs between 
high and low pathogenic avian influenza viruses. 
Furthermore, we have made reagents that will be used for further studies of RNA 
interference and many other aspects of NS1 function. 
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